Skip to main content

Table 2 Characteristics of survey respondents (n = 1140)

From: Management of chronic spontaneous urticaria: a worldwide perspective

Characteristics of respondents

Geographical regions

Total

% (n)

NA

% (n/total)

LA

% (n/total)

EU

% (n/total)

AME

% (n/total)

AP

% (n/total)

Specialtya (n = 1138)

 Allergists/ Clinical Immunologists

98.2 (324/330)

97.4 (187/192)

83.1 (315/379)

79.7 (51/64)

76.9 (133/173)

88.7 (1010)

 Dermatologists

0.3 (1/330)

0.5 (1/192)

9.8 (37/379)

0

6.9 (12/173)

4.5 (51)

 Pediatricians

4.2 (14/330)

25.5 (49/192)

17.4 (66/379)

23.4 (15/64)

25.4 (44/173)

16.5 (188)

 General Practitioners

0.6 (2/330)

3.1 (6/192)

1.6 (6/379)

6.2 (4/64)

4 (7/173)

2.2 (25)

Gender (n = 1117)

 Male

58.5 (189/323)

55.1 (102/185)

43.7 (163/373)

57.1 (36/63)

58.4 (101/173)

53.0 (591)

 Female

41.5 (134/323)

44.9 (83/185)

56.3 (210/373)

42.9 (27/63)

41.6 (72/173)

47.0 (526)

Age, years (n = 1132)

 < 40

22.9 (75/327)

27.6 (53/192)

28.2 (106/376)

17.2 (11/64)

23.1 (133/173)

25.2 (285)

 ≥40

77.1 (252/327)

72.4 (139/192)

71.8 (270/376)

82.8 (53/64)

76.9 (133/173)

74.8 (847)

Clinical experience, years (n = 1130)

 ≤19

50.3 (164/326)

53.9 (104/193)

58.2 (217/373)

60.9 (39/64)

63.2 (110/174)

56.1 (634)

 Over 19

49.7 (162/326)

46.1 (89/193)

41.8 (156/373)

39.1 (25/64)

36.8 (64/174)

43.9 (496)

Place of worka (n = 1140)

 Private practice

63.9 (211/330)

82.4 (159/193)

34.6 (131/379)

54.7 (35/64)

46.0 (80/174)

54.0 (616)

 University clinic

70.3 (232/330)

68.4 (132/193)

57.5 (218/379)

59.4 (38/64)

71.8 (125/174)

65.3 (745)

 Hospital

11.8 (39/330)

39.4 (76/193)

43.3 (164/379)

42.2 (27/64)

58.6 (102/174)

35.8 (408)

 Specialized urticaria centre

0.9 (3/330)

4.7 (9/193)

2.9 (11/379)

3.1 (2/64)

0.3 (3/174)

2.4 (28)

Department (n = 1140)

 Outpatients

97.3 (321/330)

89.6 (173/193)

82.3 (312/379)

81.3 (52/64)

89.1 (155/174)

88.9 (1013)

 Inpatients

0.9 (3/330)

8.8 (17/193)

12.4 (47/379)

10.9 (7/64)

6.9 (12/174)

7.5 (86)

 Outpatients and inpatients

1.8 (6/330)

1.6 (3/193)

5.3 (20/379)

7.8 (5/64)

4.0 (7/174)

3.6 (41)

Age of patients (n = 1131)

 Adults

16.5 (54/327)

17.2 (33/192)

42.0 (158/376)

10.9 (7/64)

30.8 (53/172)

27.0 (305)

 Children

9.5 (31/327)

16.7 (32/192)

19.4 (73/376)

18.8 (12/64)

27.9 (71/172)

19.3 (219)

 Adults and children

74.0 (242/327)

66.1 (127/192)

38.6 (145/376)

70.3 (45/64)

41.3 (48/172)

53.7 (607)

Number of CSU patients per week (n = 1127)

< 10

75.5 (247/327)

78.8 (152/193)

80.7 (302/374)

71.0 (44/62)

78.4 (134/171)

78.0 (879)

≥10

24.5 (80/327)

21.2 (41/193)

19.3 (72/374)

29.0 (18/62)

21.6 (37/171)

22.0 (248)

Patients with angioedema, % from the total number of CSU patients (n = 1131)

 ≤20

37.7 (123/326)

58.5 (113/193)

51.7 (195/377)

55.6 (35/63)

66.3 (114/172)

51.3 (580)

 > 20

62.3 (203/326)

41.5 (80/193)

48.3 (182/377)

44.4 (28/63)

33.7 (58/172)

48.7 (551)

Adherence to the urticaria guidelinesa (n = 1126)

 Follow the guidelines

Any of three below

88.0 (286/325)

93.8 (180/192)

97.3 (365/375)

85.7 (54/63)

89.5 (153/171)

92.2 (1038)

EAACI/WAO/GA2LEN/EDF

16.3 (53/325)

78.1 (150/192)

82.4 (309/375)

68.3 (43/63)

63.2 (108/171)

58.9 (663)

US practice parameters

81.2 (264/325)

32.3 (62/192)

9.1 (34/375)

28.6 (18/63)

29.8 (51/171)

38.1 (429)

National

7.1 (23/325)

26.0 (50/192)

32.5 (122/375)

14.3 (9/63)

30.4 (52/171)

22.7 (256)

Follow any but deviate

40.0 (80/200)

28.1 (25/89)

49.4 (79/160)

58.1 (18/31)

53.8 (49/91)

22.3 (251)

 Do not follow

12.0 (39/325)

6.3 (12/192)

2.7 (10/375)

14.3 (9/63)

10.5 (18/171)

7.8 (88)

  1. AME Africa/Middle-East, AP Asia-Pacific, EU Europe, LA Latin America, NA North America. arespondents could choose more than one option